A new trial will test a low-cost antibiotic aimed at reducing deaths among 8 000 patients with advanced HIV who are starting or restarting anti-retroviral therapy (ART), a combination of drugs to treat HIV. Read More
UCT and McMaster lead a new clinical trial to reduce HIV-related deaths in Africa
Reading Time: < 1 minute